Modern treatments

Psychedelic-assisted therapy in 2026: Where things stand

Published April 1, 2026 · 8 min read · Updated April 2026

Reviewed for accuracy by licensed clinical professionals.

Psychedelic-assisted therapy has moved from counterculture curiosity to serious clinical medicine. Multiple compounds are in late-stage clinical trials or legal therapeutic use.

Ketamine

Available now. Esketamine (Spravato) is FDA-approved for treatment-resistant depression. Off-label IV ketamine widely available at clinics.

Psilocybin

Oregon offers legal supervised services. Colorado developing framework. Multiple Phase 2/3 trials ongoing for depression, addiction, and PTSD. FDA Breakthrough Therapy designation.

MDMA

Phase 3 trials showed 67% PTSD remission. FDA review ongoing. If approved, would be available through certified therapists.

Important context

All therapeutic psychedelic use involves professional supervision, screening, preparation, and integration. Self-administered psychedelics carry significant risks and do not replicate clinical outcomes.

Authoritative sources

This article references guidelines from: NIH · NAMI · APA

Frequently asked questions

Can I get psychedelic therapy now?

Ketamine therapy is widely available. Psilocybin is available in Oregon through licensed facilitators. MDMA awaits FDA decision.

Is psychedelic therapy legal?

Ketamine is legal. Psilocybin legal in Oregon, decriminalized in Colorado. MDMA and psilocybin remain Schedule I federally.

Is psychedelic therapy safe?

In supervised clinical settings with screening, the safety profile is strong. Self-administration carries risks.

Disclaimer: Informational only. Not medical advice. SAMHSA: 1-800-662-4357.